Springer Nature OA
open access
CC BY 4.0
Imaging of MASLD: clinical standards and novel methods
Non-invasive imaging is central to the diagnosis and staging of metabolic dysfunction-associated steatotic liver disease (MASLD). Various non-invasive means are used to reliably diagnose steatosis, whereas liver biopsy remains the gold standard for MASLD staging, as it enables assessment of the seve
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes#834735
- Pharmacological treatment of MASH#1148616
- Non-Invasive Diagnostic Tests for MASLD in Pediatric Population#824882
- AI-driven diagnostic and prognostic models for metabolic dysfunction-associated steatotic liver disease: insights from clinical, imaging, and multi-omics studies-a scoping review.#685641
- A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease#804870
Record · ID 1148617
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive